Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study
Claudia Crimi(Marconi University), Nunzio Crimi(University of Catania), Raffaele Campisi(University of Catania), Corrado Pelaia(Azienda Ospedaliero Universitario Mater Domini), Santi Nolasco(University of Catania), Rossella Intravaia(University of Catania), Pietro Impellizzeri(University of Catania), Morena Porto(University of Catania), Giulia Cacopardo(University of Catania)
Cited by 57
Related Papers
A European survey of noninvasive ventilation practices
|European Respiratory Journal|2010|205
Determinants of tracheostomy decannulation: an international survey
|Critical Care|2008|177
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
|Frontiers in Pharmacology|2022|157
Molecular Targets for Biological Therapies of Severe Asthma
|Frontiers in Immunology|2020|132